As all of the articles published in Cancers (ISSN: 2072-6694) are open access, you have free and unlimited access to the full text of all articles. We welcome you to read our most highly cited papers published in 2023 in the Section “Cancer Biomarkers”, which are listed below:

1. “Advances in Genomic Data and Biomarkers: Revolutionizing NSCLC Diagnosis and Treatment”
by Juan Carlos Restrepo, Diana Dueñas, Zuray Corredor and Yamil Liscano
Cancers 2023, 15(13), 3474; https://doi.org/10.3390/cancers15133474   
Available online: https://www.mdpi.com/2072-6694/15/13/3474

2. “Performance of Node-RADS Scoring System for a Standardized Assessment of Regional Lymph Nodes in Bladder Cancer Patients”
by Costantino Leonardo, Rocco Simone Flammia, Sara Lucciola, Flavia Proietti, Martina Pecoraro, Bruno Bucca, Leslie Claire Licari, Antonella Borrelli, Eugenio Bologna, Nicholas Landini et al.
Cancers 2023, 15(3), 580; https://doi.org/10.3390/cancers15030580  
Available online: https://www.mdpi.com/2072-6694/15/3/580

3. “Emerging Biosensing Methods to Monitor Lung Cancer Biomarkers in Biological Samples: A Comprehensive Review”
by Raja Chinnappan, Tanveer Ahmad Mir, Sulaiman Alsalameh, Tariq Makhzoum, Alaa Alzhrani, Khalid Alnajjar, Salma Adeeb, Noor Al Eman, Zara Ahmed, Ismail Shakir et al.
Cancers 2023, 15(13), 3414; https://doi.org/10.3390/cancers15133414  
Available online: https://www.mdpi.com/2072-6694/15/13/3414

4. “PET/CT with Fibroblast Activation Protein Inhibitors in Breast Cancer: Diagnostic and Theranostic Application—A Literature Review”
by Silvia Taralli, Margherita Lorusso, Elisabetta Perrone, Germano Perotti, Luca Zagaria and Maria Lucia Calcagni
Cancers 2023, 15(3), 908; https://doi.org/10.3390/cancers15030908  
Available online: https://www.mdpi.com/2072-6694/15/3/908

5. “Discordance of HER2-Low between Primary Tumors and Matched Distant Metastases in Breast Cancer”
by Katrin Almstedt, Lisa Krauthauser, Franziska Kappenberg, Daniel-Christoph Wagner, Anne-Sophie Heimes, Marco J. Battista, Katharina Anic, Slavomir Krajnak, Antje Lebrecht, Roxana Schwab et al.
Cancers 2023, 15(5), 1413; https://doi.org/10.3390/cancers15051413  
Available online: https://www.mdpi.com/2072-6694/15/5/1413

6. “LncRNA HCP5-Encoded Protein Regulates Ferroptosis to Promote the Progression of Triple-Negative Breast Cancer”
by Xiao Tong, Zhengling Yu, Jiani Xing, Haizhou Liu, Shunheng Zhou, Yu’e Huang, Jing Lin, Wei Jiang and Lihong Wang
Cancers 2023, 15(6), 1880; https://doi.org/10.3390/cancers15061880  
Available online: https://www.mdpi.com/2072-6694/15/6/1880

7. “Clinical and Histopathological Features of an Italian Monocentric Series of Primary Small Bowel T-Cell Lymphomas”
by Marco Lucioni, Sara Fraticelli, Giovanni Santacroce, Arturo Bonometti, Nicola Aronico, Roberta Sciarra, Marco Vincenzo Lenti, Paola Ilaria Bianchi, Giuseppe Neri, Monica Feltri et al.
Cancers 2023, 15(10), 2743; https://doi.org/10.3390/cancers15102743  
Available online: https://www.mdpi.com/2072-6694/15/10/2743

8. “Emerging Role of IGF-1 in Prostate Cancer: A Promising Biomarker and Therapeutic Target”
by Guoqiang Liu, Minggang Zhu, Mingrui Zhang and Feng Pan
Cancers 2023, 15(4), 1287; https://doi.org/10.3390/cancers15041287  
Available online: https://www.mdpi.com/2072-6694/15/4/1287

9. “Body Composition of Patients Undergoing Radical Cystectomy for Bladder Cancer: Sarcopenia, Low Psoas Muscle Index, and Myosteatosis Are Independent Risk Factors for Mortality”
by Simon U. Engelmann, Christoph Pickl, Maximilian Haas, Sebastian Kaelble, Valerie Hartmann, Maximilian Firsching, Laura Lehmann, Miodrag Gužvić, Bas W. G. van Rhijn, Johannes Breyer et al.
Cancers 2023, 15(6), 1778; https://doi.org/10.3390/cancers15061778  
Available online: https://www.mdpi.com/2072-6694/15/6/1778

10. “The Antithetic Roles of IQGAP2 and IQGAP3 in Cancers”
by Fei Song, Qingqing Dai, Marc-Oliver Grimm and Daniel Steinbach
Cancers 2023, 15(4), 1115; https://doi.org/10.3390/cancers15041115  
Available online: https://www.mdpi.com/2072-6694/15/4/1115

11. “Unlocking the Potential of Circulating miRNAs in the Breast Cancer Neoadjuvant Setting: A Systematic Review and Meta-Analysis”
by Paola Tiberio, Mariangela Gaudio, Silvia Belloni, Sebastiano Pindilli, Chiara Benvenuti, Flavia Jacobs, Giuseppe Saltalamacchia, Alberto Zambelli, Armando Santoro and Rita De Sanctis
Cancers 2023, 15(13), 3424; https://doi.org/10.3390/cancers15133424  
Available online: https://www.mdpi.com/2072-6694/15/13/3424

12. “Assessment of Barriers and Challenges to Screening, Diagnosis, and Biomarker Testing in Early-Stage Lung Cancer”
by Reza Zarinshenas, Arya Amini, Isa Mambetsariev, Tariq Abuali, Jeremy Fricke, Colton Ladbury and Ravi Salgia
Cancers 2023, 15(5), 1595; https://doi.org/10.3390/cancers15051595  
Available online: https://www.mdpi.com/2072-6694/15/5/1595

13. “RBM15 Promates the Proliferation, Migration and Invasion of Pancreatic Cancer Cell Lines”
by Hui Dong, Haidong Zhang, Xinyu Mao, Shiwei Liu, Wenjing Xu and Yewei Zhang
Cancers 2023, 15(4), 1084; https://doi.org/10.3390/cancers15041084  
Available online: https://www.mdpi.com/2072-6694/15/4/1084

14. “The Importance of Detecting, Quantifying, and Characterizing Exosomes as a New Diagnostic/Prognostic Approach for Tumor Patients”
by Mariantonia Logozzi, Nicola Salvatore Orefice, Rossella Di Raimo, Davide Mizzoni and Stefano Fais
Cancers 2023, 15(11), 2878; https://doi.org/10.3390/cancers15112878  
Available online: https://www.mdpi.com/2072-6694/15/11/2878

15. “Accurate Detection of Urothelial Bladder Cancer Using Targeted Deep Sequencing of Urine DNA”
by Dongin Lee, Wookjae Lee, Hwang-Phill Kim, Myong Kim, Hyun Kyu Ahn, Duhee Bang and Kwang Hyun Kim
Cancers 2023, 15(10), 2868; https://doi.org/10.3390/cancers15102868
Available online: https://www.mdpi.com/2072-6694/15/10/2868

You are invited to view and submit relevant papers to the journal Cancers.

Cancers Editorial Office